| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/16/2010 | US20100233732 Methods of Determining Patient Response By Measurement of HER-2 Expression |
| 09/16/2010 | US20100233731 Detection and measurement of blood-feeding activity |
| 09/16/2010 | US20100233730 Therapeutic modulation of autophagy |
| 09/16/2010 | US20100233729 Detecting interactions at biomimetic interfaces with liquid crystals |
| 09/16/2010 | US20100233728 Method and kit for detecting the early onset of renal tubular cell injury |
| 09/16/2010 | US20100233727 Marker for arrhythmia risk |
| 09/16/2010 | US20100233726 Tandem fluorescent protein constructs |
| 09/16/2010 | US20100233725 Immunoassays employing non-particulate chemiluminescent reagent |
| 09/16/2010 | US20100233724 Markers of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) and methods of use thereof |
| 09/16/2010 | US20100233723 Dry stick device and method for determining an analyte in a sample |
| 09/16/2010 | US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 09/16/2010 | US20100233721 Apparatus and methods for detecting dna in biological samples |
| 09/16/2010 | US20100233714 Multistate affinity ligands for the separation and purification of antibodies, antibody fragments and conjugates of |
| 09/16/2010 | US20100233712 Method for Early Detection of Cancers |
| 09/16/2010 | US20100233708 Split flow device for analyses of specific-binding partners |
| 09/16/2010 | US20100233705 Method or system using biomarkers for the monitoring of a treatment |
| 09/16/2010 | US20100233696 Methods, flow cells and systems for single cell analysis |
| 09/16/2010 | US20100233694 Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| 09/16/2010 | US20100233693 Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
| 09/16/2010 | US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 09/16/2010 | US20100233682 Fluid processing and volume determination system |
| 09/16/2010 | US20100233680 Gene Expression Profiles and Methods of Use |
| 09/16/2010 | US20100233678 Tunable affinity ligands for the separation and detection of target substances |
| 09/16/2010 | US20100233329 Recording of position-specific wavelength absorption spectra |
| 09/16/2010 | US20100233327 System and method for formulating compositions of concentrated liquid sweeteners for individual servings in recyclable and compostable packaging |
| 09/16/2010 | US20100233249 Contraceptive methods and compositions related to proteasomal interference |
| 09/16/2010 | US20100233189 Crystal structure |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233185 Caries Risk Test for Predicting and Assessing the Risk of Disease |
| 09/16/2010 | US20100233182 Antibodies against Clostridium difficile toxins and uses thereof |
| 09/16/2010 | US20100233181 Antibodies against clostridium difficile toxins and uses thereof |
| 09/16/2010 | US20100233176 Methods and systems for predicting misfolded protein epitopes |
| 09/16/2010 | US20100233175 Antibodies relating to pivkaii and uses thereof |
| 09/16/2010 | US20100233174 Anthrax carbohydrates, synthesis and uses thereof |
| 09/16/2010 | US20100233172 Methods of inhibiting quiescent tumor proliferation |
| 09/16/2010 | US20100233171 Differential Drug Sensitivity |
| 09/16/2010 | US20100233170 Fully human antibodies against N-Cadherin |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233165 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 09/16/2010 | US20100233162 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
| 09/16/2010 | US20100233160 Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate Carcinoma |
| 09/16/2010 | US20100233155 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/16/2010 | US20100233152 Use of HMGB proteins and nucleic acids that code therefor |
| 09/16/2010 | US20100233095 Conformationally dynamic peptides |
| 09/16/2010 | US20100233088 Method of identifying strategies for treatment or prevention of ventricular fibrilation and ventricular tachycardia |
| 09/16/2010 | US20100233080 Antigen Binding Molecules that Bind EGFR, Vectors Encoding Same, and Uses Thereof |
| 09/16/2010 | US20100233062 Apparatus and method for producing trichlorosilane |
| 09/16/2010 | US20100233026 Device and method for pressure-driven plug transport and reaction |
| 09/16/2010 | US20100233025 Containers For Reading And Handling Diagnostic Reagents And Methods For Using The Same |
| 09/16/2010 | US20100232675 Blood and cell analysis using an imaging flow cytometer |
| 09/16/2010 | US20100231907 Method and Apparatus for Biosensor Spectral Shift Detection |
| 09/16/2010 | US20100231242 Electronic sensing of biological and chemical agents using functionalized nanostructures |
| 09/16/2010 | US20100230612 Method of analysis of samples by determination of a function of specific brightness |
| 09/16/2010 | US20100229641 Anchor bolt and annularly grooved expansion sleeve assembly exhibiting high pull-out resistance, particularly under cracked concrete test conditions |
| 09/16/2010 | US20100229633 Spot Test Kit For Explosives Detection |
| 09/16/2010 | US20100229627 Protective equipment for particulate matter detection device |
| 09/16/2010 | DE102009012990A1 Cardiovascular-risk e.g. heart attack, diagnostic determination improvement device, has radiation source transmitting physical radiations to carrier matrix, where assessable reaction takes place on calcium phosphate by radiation effect |
| 09/16/2010 | DE102009012446A1 Verfahren zur Bestimmung der Viskosität von Kraftstoff/Wasser- und Wasser/Kraftstoff-Emulsionen Method for determining the viscosity of the fuel / water and water / fuel emulsions |
| 09/16/2010 | DE102009012391A1 Device for diagnostic screening of cardiovascular risks such as heart attack, coronary heart disease or hypertension, comprises multiple component system including container and carrier matrix |
| 09/16/2010 | DE102009011600A1 Method for determining thermal conductivity of soil layers along vertical borehole, involves carrying out determination of thermal conductivity of each soil layer at each remote drilling tool by measuring device in partial manner |
| 09/16/2010 | DE102009001455A1 Sampling device for attachment to e.g. hollow needle for sampling blood of human in chemical industry, has probe chamber formed as inner recess, and separation membrane surrounding inner recess for penetrating analytes from probe chamber |
| 09/16/2010 | DE102005036363B4 Vorrichtung zur Erfassung der Schadstoffbelastung im Belebtschlamm einer biologischen Kläranlage Device for detecting the pollution in the activated sludge of a biological wastewater treatment plant |
| 09/16/2010 | CA2755341A1 Method |
| 09/16/2010 | CA2755301A1 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 09/16/2010 | CA2755276A1 Method for measuring physiologically active substance of biological origin, program for implementing the same, and apparatus for measuring physiologically active substance of biological origin |
| 09/16/2010 | CA2755219A1 Antibodies binding to pivka-ii amino acids 13-27 |
| 09/16/2010 | CA2755055A1 Method or system using biomarkers for the monitoring of a treatment |
| 09/16/2010 | CA2754917A1 Low molecular weight cyclin e (lmw-e) as a biomarker for personalization of cancer therapies |
| 09/16/2010 | CA2754862A1 Anti-cd40 antibodies and uses thereof |
| 09/16/2010 | CA2754771A1 Faecal markers |
| 09/16/2010 | CA2754741A1 Compositions and methods for characterizing arthritic conditions |
| 09/16/2010 | CA2754678A1 Improvement of tumour treatment |
| 09/16/2010 | CA2754591A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 09/16/2010 | CA2753894A1 Immuno-based retargeted endopeptidase activity assays |
| 09/16/2010 | CA2753883A1 A pkn3/rhoc macromolecular complex and methods of use therefor |
| 09/16/2010 | CA2753881A1 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 09/16/2010 | CA2735242A1 Cells useful for immuno-based botulinum toxin serotype a activity assays |
| 09/15/2010 | EP2228657A1 Microchip and blood monitoring device |
| 09/15/2010 | EP2228656A2 A method for quantification of allergens |
| 09/15/2010 | EP2228655A1 Method of predicting metastatic potential, poor prognosis or lower overall survival of cancer patients |
| 09/15/2010 | EP2228654A2 Diagnosis and prevention of cancer cell invasion |
| 09/15/2010 | EP2228653A2 Multichemistry measuring device and test strips |
| 09/15/2010 | EP2228652A1 Improvement of tumour treatment |
| 09/15/2010 | EP2228651A1 IP-10 Based Immunological Monitoring |
| 09/15/2010 | EP2228645A1 Measurement method, measurement device, and measurement apparatus for creatinine concentration and measurement method, measurement device, and measurement apparatus for amount of salinity using the same |
| 09/15/2010 | EP2228642A1 Systems and methods for improving electrochemical analyte sensors |
| 09/15/2010 | EP2228641A1 Device and method for calibrating a capacitive moisture content measurement apparatus |
| 09/15/2010 | EP2228640A1 Method for determining the moisture content of wood |
| 09/15/2010 | EP2228452A1 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent |
| 09/15/2010 | EP2228447A2 Cloning and characterizing of genes associated with long-term memory |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228445A1 Fucose Transporter |
| 09/15/2010 | EP2228436A1 Centrifugation and filtration methods for concentrating microorganisms |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228363A1 Kit for use in production of molecular probe for pet drug screening |
| 09/15/2010 | EP2228183A2 Method for identifying the cutting pattern for pieces of wood such as logs |
| 09/15/2010 | EP2228075A1 Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same |
| 09/15/2010 | EP2228072A1 Cancer vaccine composition |